- Home
- TIL vs ARAY Comparison
TIL vs ARAY Comparison
Compare TIL & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- ARAY
- Stock Information
- Founded
- TIL 2018
- ARAY 1990
- Country
- TIL United States
- ARAY United States
- Employees
- TIL N/A
- ARAY N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- TIL Health Care
- ARAY Health Care
- Exchange
- TIL Nasdaq
- ARAY Nasdaq
- Market Cap
- TIL 177.1M
- ARAY 170.1M
- IPO Year
- TIL 2021
- ARAY 2007
- Fundamental
- Price
- TIL $20.99
- ARAY $1.86
- Analyst Decision
- TIL Strong Buy
- ARAY Strong Buy
- Analyst Count
- TIL 5
- ARAY 1
- Target Price
- TIL $100.67
- ARAY $5.00
- AVG Volume (30 Days)
- TIL 165.7K
- ARAY 826.4K
- Earning Date
- TIL 11-12-2025
- ARAY 11-05-2025
- Dividend Yield
- TIL N/A
- ARAY N/A
- EPS Growth
- TIL N/A
- ARAY N/A
- EPS
- TIL N/A
- ARAY N/A
- Revenue
- TIL N/A
- ARAY $458,505,000.00
- Revenue This Year
- TIL N/A
- ARAY $5.70
- Revenue Next Year
- TIL N/A
- ARAY $4.05
- P/E Ratio
- TIL N/A
- ARAY N/A
- Revenue Growth
- TIL N/A
- ARAY 2.68
- 52 Week Low
- TIL $10.80
- ARAY $1.14
- 52 Week High
- TIL $45.07
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- TIL 49.49
- ARAY 61.94
- Support Level
- TIL $17.37
- ARAY $1.58
- Resistance Level
- TIL $21.45
- ARAY $1.75
- Average True Range (ATR)
- TIL 1.48
- ARAY 0.09
- MACD
- TIL 0.47
- ARAY -0.00
- Stochastic Oscillator
- TIL 89.09
- ARAY 94.27
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.